Elliott Management turns up heat on embattled Glaxo chief
London stock market listing of up to £45bn looms as GSK investors
The Curious Case Of Elliott Advisors And GSK: Are Activist
Elliott Management turns up heat on embattled Glaxo chief
Elliott Publishes Letter on GlaxoSmithKline
2442c234-fbba-4ec0-8a9f-6f3dc585c22d.jpg
c4dd235f-344a-4a70-b5da-c62bdfde6c41.jpg
Sir Jonathan Symonds — Department of Pharmacology
940294d2-50db-4d07-90a5-f7d31dca1820.jpg
Sir Jonathan Symonds CBE
GSK investor support for spin-off vindicates rejection of Unilever